Article info
PDFOriginal research
Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure
- Correspondence to Professor Sarfraz Ahmad, Gynecologic Oncology, Advent Health Cancer Institute, Orlando, Florida, USA; sarfraz.ahmad{at}AdventHealth.com
Citation
Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure
Publication history
- Received September 10, 2019
- Revision received November 21, 2019
- Accepted December 3, 2019
- First published December 18, 2019.
Article Versions
- You are currently viewing a Previous version of this article (2 March 2020).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.